# ChatTogoVar

There is no direct information from the TogoVar API or other sources about the SNP **rs121913529** influencing drug metabolism or response. This variant is primarily associated with cancer-related conditions in various contexts (e.g., pancreatic cancer, lung adenocarcinoma, colorectal cancer, etc.) and functions as an oncogenic driver due to its role in the **KRAS** gene. Most of the associations for rs121913529 concern pathological processes rather than drug metabolism or pharmacogenomic profiles.

For further details, you can explore additional pharmacogenomic databases or studies not listed here.

Sources:
- [TogoVar Page for rs121913529](https://togovar.biosciencedbc.jp/variant/rs121913529)
- [ClinVar Entry for rs121913529](https://www.ncbi.nlm.nih.gov/clinvar/variation/12582)